Global Cystic Fibrosis Therapeutics Market 2016-2020

Published: October 2016
No. of Pages: 80
    ReportsandReports

Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, high salt content in the sweat, and secretion of abnormally viscous mucus. The principal indicators of cystic fibrosis in patients are pancreatic insufficiency, pancreatitis, chronic bronchitis, adolescent diabetes, male sterility, and very rarely liver cirrhosis or intestinal obstruction. The most usual forms of cystic fibrosis are those with respiratory complications, difficulties related to digestion, and anomalies in height and growth. The mortality and morbidity of a patient are dependent on the degree of bronchopulmonary involvement.

The analysts forecast global cystic fibrosis therapeutics market to grow at a CAGR of 31.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cystic fibrosis therapeutics market for 2016-2020. The report has taken into consideration the revenue generated by the vendors in the PET packaging market for packaging of different goods.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

This report, Global Cystic Fibrosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AbbVie
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • Novartis
  • Vertex Pharmaceuticals

Other prominent vendors

  • Advanced Inhalation Therapies (AIT)
  • Alaxia SAS
  • Alcresta Therapeutics
  • AlgiPharma
  • Allergan
  • Anthera
  • AstraZeneca
  • Bayer
  • Celtaxsys
  • Chiesi Farmaceutici
  • Corbus Pharmaceuticals
  • Cyclacel Pharmaceuticals
  • Digestive Care
  • Galapagos
  • Grifols
  • Insmed Incorporated
  • Kamada
  • Nivalis Therapeutics
  • Novoteris
  • Parion Sciences
  • Pharmaxis
  • ProQR Therapeutics
  • Protalix Biotherapeutics
  • Proteostasis Therapeutics
  • PTC Therapeutics
  • Pulmatrix
  • Savara
  • SolAeroMed
  • Vectura

Market driver

  • Special regulatory designations for drugs
  • For a full, detailed list, view our report

Market challenge

  • Discontinuation of drugs from development
  • For a full, detailed list, view our report

Market trend

  • Co-pay and assistance programs by vendors
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Published By: Technavio
Product Code: Infiniti Research Limited13481


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • Asia-Pacific Thin Film Drugs Market Report 2017

    In this report, the Asia-Pacific Thin Film Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific ...

  • Asia-Pacific Rabies Vaccine Market Report 2017

    In this report, the Asia-Pacific Rabies Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific i...

  • Asia-Pacific Placental Protein Market Report 2017

    In this report, the Asia-Pacific Placental Protein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacifi...

  • Asia-Pacific Placenta Market Report 2017

    In this report, the Asia-Pacific Placenta market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into se...

  • Asia-Pacific Placenta Extract Market Report 2017

    In this report, the Asia-Pacific Placenta Extract market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific...

  • Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2017

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2017, provides an overview of the Ret...

  • Merkel Cell Carcinoma - Pipeline Review, H1 2017

    Merkel Cell Carcinoma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Merkel Cell Carcinoma - Pipeline Review, H1 2017, provides an overview of the Merkel Cell Carcinoma (On...

  • Neuroendocrine Tumors - Pipeline Review, H1 2017

    Neuroendocrine Tumors - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors - Pipeline Review, H1 2017, provides an overview of the Neuroendocrine Tumors (On...

  • Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017, provides an overview ...

  • High-Grade Glioma - Pipeline Review, H1 2017

    High-Grade Glioma - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide High-Grade Glioma - Pipeline Review, H1 2017, provides an overview of the High-Grade Glioma (Oncology) pipe...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: